MedPath

Lannett Company Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

FDA:3

Drug Approvals

MESALAMINE

Approval Date
Jun 3, 2023
FDA

TRIENTINE HYDROCHLORIDE

Approval Date
Dec 2, 2022
FDA

POSACONAZOLE

Approval Date
Aug 5, 2022
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.